Edition:
United States

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

3.50USD
4:00pm EDT
Change (% chg)

$0.05 (+1.45%)
Prev Close
$3.45
Open
$3.50
Day's High
$3.50
Day's Low
$3.40
Volume
6,281
Avg. Vol
34,092
52-wk High
$5.44
52-wk Low
$2.12

All Insider Trades
Trading Date Name Title Type Shares Traded Price
20 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 10,000 $2.28
19 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 15,000 $2.27
19 Dec 2016

Amanullah (Ashraf)

Officer Buy 11,000 $2.25
18 Dec 2016

Mendlein (John D)

Chief Executive Officer Buy 69,000 $2.20
15 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 10,000 $2.40
14 Dec 2016

Schimmel (Paul R Ph.D.)

Director Buy 40,000 $2.50
22 Sep 2016

Schimmel (Paul R Ph.D.)

Director Gift 12,572 $0.00
22 Sep 2016

Schimmel (Paul R Ph.D.)

Director Gift 12,572 $0.00
10 May 2016

Matsuoka (Grove)

Officer Buy 10,000 $3.03
8 May 2016

Matsuoka (Grove)

Officer Buy 2,412 $3.08
13 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 33,619 $4.22
13 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 32,600 $4.14
12 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 9,835 $3.85
11 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 2,581 $3.75
11 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 6,546 $3.70
10 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 27,359 $3.59
10 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 5,300 $3.45
7 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 85,000 $3.22
6 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 40,000 $3.19
5 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 25,000 $3.20
4 Apr 2016

Schimmel (Paul R Ph.D.)

Director Buy 25,000 $3.52
4 Apr 2016

Mendlein (John D)

Chief Executive Officer Buy 2,500 $3.55
4 Apr 2016

Mendlein (John D)

Chief Executive Officer Buy 2,500 $3.52
15 Sep 2015

Schimmel (Paul R Ph.D.)

Director Gift 11,925 $0.00
11 May 2015

Alta Partners VIII, L.P.

Beneficial Owner of More than 10% Class Buy 1,685,758 $0.00

Institutional Holders

% Shares Owned: 80.47%
# of Holders: 62
Total Shares Held: 19,110,857
3 Mo. Net Change: 263,584
# New Positions: 13
# Closed Positions: 7
# Increased Positions: 25
# Reduced Positions: 19
# Net Buyers: 6

Officers & Directors

Name Age Since Current Position

John Mendlein

56 2011 Chief Executive Officer and Executive Chairman, Board of Directors

John Clarke

63 2005 Non-Executive Independent Chairman of the Board

John Blake

39 2016 Principal Financial Officer, Chief Accounting Officer

David King

2016 Senior Vice President - Research

Melissa Ashlock

57 2011 Vice President - External Scientific Alliances and Human Genetics

Holly Chrzanowski

49 2013 Vice President - Enterprise Talent and Organization

Andrew Cubitt

52 2011 Vice President - Product Protection

John McKew

51 2014 Vice President - Research

Fred Ramsdell

54 2014 Vice President - Immunology

Sanuj Ravindran

2016 Chief Business Officer

Sanjay Shukla

2016 Chief Medical Officer

Srinivas Akkaraju

48 2015 Non-Executive Independent Director

James Blair

76 2010 Non-Executive Independent Director

Kathryn Falberg

55 2014 Non-Executive Independent Director

Mark Goldberg

61 2015 Non-Executive Independent Director

Amir Nashat

38 2006 Non-Executive Independent Director

Paul Schimmel

76 2005 Non-Executive Independent Director